Literature DB >> 9052841

Editing disease-associated autoantibodies.

C Chen1, E L Prak, M Weigert.   

Abstract

We have generated site-directed transgenic mice whose transgenes code for anti-DNA antibodies. These antibodies are representative of the lupus-associated anti-DNAs seen in mouse models of autoimmunity and human SLE, and have the usual characteristics of pathogenic autoantibodies. As conventional transgenics in nonautoimmune mice, anti-DNA B cells have been shown to be deleted or inactivated. Autoreactive B cells can also escape negative regulation by a process called receptor editing. Here we describe two combined immunoglobulin H and L chain site-directed transgenic mouse models and characterize their editing phenotypes. One model, 3H9R/Vkappa4R, has a deletion-prone phenotype and undergoes editing, primarily by inactivation of the light chain by leap-frogging events. In the other model, 3H9R/Vkappa8R, B cells are susceptible to anergy and maintain most of their HR and LR chains. These studies clarify the relationship between editing and other mechanisms of tolerance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9052841     DOI: 10.1016/s1074-7613(00)80673-1

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  63 in total

1.  B cell receptor expression level determines the fate of developing B lymphocytes: receptor editing versus selection.

Authors:  V Kouskoff; G Lacaud; K Pape; M Retter; D Nemazee
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

Review 2.  Role of B cell antigen receptor in regulation of V(D)J recombination and cell survival.

Authors:  D Nemazee
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 3.  Receptor selection in B and T lymphocytes.

Authors:  D Nemazee
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

4.  Receptor revision of immunoglobulin heavy chain genes in human MALT lymphomas.

Authors:  D Lenze; A Greiner; C Knörr; I Anagnostopoulos; H Stein; M Hummel
Journal:  Mol Pathol       Date:  2003-10

Review 5.  Allelic exclusion of immunoglobulin genes: models and mechanisms.

Authors:  Christian Vettermann; Mark S Schlissel
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

6.  Analysis of expressed and non-expressed IGK locus rearrangements in chronic lymphocytic leukemia.

Authors:  Chrysoula Belessi; Kostas Stamatopoulos; Anastasia Hadzidimitriou; Katerina Hatzi; Tatjana Smilevska; Niki Stavroyianni; Fotini Marantidou; George Paterakis; Athanasios Fassas; Achilles Anagnostopoulos; Nikolaos Laoutaris
Journal:  Mol Med       Date:  2005 Jan-Dec       Impact factor: 6.354

Review 7.  Understanding B-cell tolerance through the use of immunoglobulin transgenic models.

Authors:  Kirthi Raman Kumar; Chandra Mohan
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

8.  Immunoglobulin kappa chain receptor editing in systemic lupus erythematosus.

Authors:  T Dörner; S J Foster; N L Farner; P E Lipsky
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

9.  Contribution of V(H) replacement products to the generation of anti-HIV antibodies.

Authors:  Hongyan Liao; Jun-tao Guo; Miles D Lange; Run Fan; Michael Zemlin; Kaihong Su; Yongjun Guan; Zhixin Zhang
Journal:  Clin Immunol       Date:  2012-11-15       Impact factor: 3.969

10.  Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance.

Authors:  Laurent Verkoczy; Marilyn Diaz; T Matt Holl; Ying-Bin Ouyang; Hilary Bouton-Verville; S Munir Alam; Hua-Xin Liao; Garnett Kelsoe; Barton F Haynes
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.